
|Videos|October 1, 2016
Shared Decision-Making in Hematologic Malignancies
Author(s)Thomas W. LeBlanc, MD, MA
In this video we discuss the goals of shared-decision making in hematologic malignancies and touch upon different scenarios where its use may be appropriate.
Advertisement
In this video, Thomas W. LeBlanc, MD, MA, of the Duke Cancer Institute in Durham, North Carolina, discusses the goals of shared-decision making when treating patients with hematologic malignancies and touches upon different scenarios where its use may be appropriate.
Dr. LeBlanc gave a presentation on this topic at the 11th Annual National Comprehensive Cancer Network (NCCN) Hematologic Malignancies Congress, held September 1–October 1 in New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
3
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
4
What Does an End-of-Life Doula Do for Patients With Cancer?
5























































